GALT financials
Galectin Therapeutics (GALT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
GALT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$20.09M | -$30.97M | -0.48 |
| 2024 | – | – | -$42.43M | -$47.20M | -0.76 |
| 2023 | – | – | -$38.07M | -$44.80M | -0.74 |
| 2022 | – | – | -$38.35M | -$38.87M | -0.65 |
| 2021 | – | – | -$30.18M | -$30.70M | -0.52 |
| 2020 | – | – | -$23.44M | -$23.60M | -0.41 |